I hereby present the Activity Report of the Valencian Institute of Oncology Foundation (IVO) for 2024. It was an especially difficult year for all the people of Valencia, including the members of this institution. Two tragedies left a deep mark: the devastating fire in the city of Valencia—the worst on record to date—and the floods on 29th October, which devastated more than 70 municipalities and claimed the lives of 227 people. Among the irreparable losses, we have mourned the loss of Mr. Antonio Noblejas Sánchez-Migallón, patron of this foundation for almost two decades. Throughout the years, his dedication, generosity, and support were fundamental in promoting our work at the service of cancer patients in Valencia. His legacy will always remain in our memory.
In this highly complex context, I have witnessed the exceptional performance and commitment of the team that makes up our institution. Faced with the challenge of ensuring continuity of care in the areas affected by the cold drop and preventing interruptions in treatment and interventions, the commitment of our professionals and the synergy among the different teams allowed patients to receive the care they needed. My sincere appreciation and thanks to all of them.
As these pages reflect, the IVO has once again put all its efforts and resources at the service of society in the arduous task of fighting cancer. As part of this mission, more than 31,600 Valencian patients have been cared for. This trust is what drives us to continue improving every day in order to offer the best humane and professional care possible.
This year, we have managed to improve our position in the Newsweek 2025 ranking, placing us among the 100 best oncology hospitals in the world for the fifth consecutive year. In addition, we have renewed our OECI (Organisation of European Cancer Institutes) certification and obtained ESMO (European Society for Medical Oncology) accreditation, as well as National Security Scheme (ENS, for the spanish abbreviation) certification, which guarantees compliance with the highest standards of patient information protection.
Alongside these milestones, in 2024:
The IVO has focused all its efforts on providing quality, personalised, and cutting-edge care service, keeping cancer patients and their families at the heart of our work.
Manuel Llombart Fuertes
CEO of the IVO Foundation
We face 2025 with the same enthusiasm to maintain and promote this institution as a centre of reference for healthcare, research, and teaching when it comes to caring for cancer patients. Nearing 50 years of history, we reaffirm our commitment to excellence, innovation, and, above all, to our patients and their families.